• 11/25/2024

Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That

Wall Street Journal

Madrigal and other companies focused on treating fatty liver disease won’t get sidelined by obesity drugs.

https://www.wsj.com/articles/ozempic-cant-do-it-alla-potential-new-blockbuster-is-a-reminder-of-that-4e52758a